CDSCO UID IMP/IVD/2020/000341_693446b6ba101238a032e2307abf70e1_8f925df88629c38dfd40ef27e49833c9

Cellex qSARS-CoV-2 IgG/IgM Cassette Rapid Test

Inbios India·Device Class Class C·India CDSCO·Brand: Cellex

Registration details

UID: IMP/IVD/2020/000341_693446b6ba101238a032e2307abf70e1_8f925df88629c38dfd40ef27e49833c9
Device class: Class C
Brand name: Cellex
License holder: Inbios India
Approving authority: CDSCO
Product information: The Cellex qSARS-CoV-2 IgG/IgM Cassette Rapid Test is a lateral flow immunoassay for qualitative detection of antibodies to 2019 novel coronavirus (Cellex) in serum、 plasma or whole blood specimens.

Similar products (1)

Other products with the same name or brand

qSARS-CoV-2 IgG/IgM Rapid Test

Brand: Cellex

Concept Healthcare

Class C

Other products from Inbios India

Products from the same license holder (9 products)

One Step Test for Novel Coronavirus IgM/IgG antibody

Brand: 2019-nCoV

Class C

Novel Coronavirus Nucleic Acid Diagnostic Kit

About this record

Cellex qSARS-CoV-2 IgG/IgM Cassette Rapid Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2020/000341_693446b6ba101238a032e2307abf70e1_8f925df88629c38dfd40ef27e49833c9. This device is marketed under the brand name Cellex. The license holder is Inbios India, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.